China National Medicines financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥1.80B ¥2.33B ¥2.81B ¥3.57B ¥4.39B ¥5.19B ¥5.92B ¥7.04B ¥8.59B ¥10.08B ¥11.54B ¥12.08B ¥34.61B ¥36.28B ¥38.74B ¥44.64B ¥40.38B ¥46.47B ¥45.50B ¥49.70B ¥0.00M
GM % Gross Margin %
10.06% 8.79% 9.10% 9.90% 9.22% 8.93% 8.90% 6.40% 6.58% 7.38% 7.92% 7.91% 7.08% 7.79% 8.83% 8.75% 7.77% 7.79% 8.39% 8.03% 0.00%
OM Operating Margin
3.38% 2.94% 3.82% 5.11% 5.02% 4.90% 5.22% 2.66% 2.75% 3.67% 4.32% 4.50% 4.41% 4.74% 4.76% 5.08% 3.88% 4.42% 4.93% 4.78% 0.00%
EPS Earnings Per Share
¥0.08 ¥0.18 ¥0.28 ¥0.40 ¥0.46 ¥0.58 ¥0.53 ¥0.69 ¥0.83 ¥0.98 ¥1.02 ¥1.13 ¥1.73 ¥2.24 ¥2.77 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.07 ¥0.00 ¥0.00 ¥0.10 ¥0.15 ¥0.00 ¥0.22 ¥0.26 ¥0.10 ¥0.10 ¥0.20 ¥0.45 ¥0.40 ¥0.64 ¥0.55 ¥0.70 ¥0.78 ¥0.85 ¥0.00
PR % Payout Ratio %
0 0 38.89% 0 0 21.74% 25.86% 0 31.88% 31.33% 10.20% 9.80% 17.70% 0 0 0 31.79% 31.25% 0 30.69% 0
Sha. Shares
478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 478.8m 766.93m 764.4m 754.5m 754.5m 754.5m 754.5m 0m 754.5m
OCF Operating Cash Flow
¥49.18M ¥0.00M ¥121.50M ¥79.48M ¥217.10M ¥255.18M ¥318.21M ¥-370.56M ¥185.87M ¥185.56M ¥218.94M ¥440.29M ¥1.04B ¥1.07B ¥981.65M ¥1.78B ¥1.30B ¥1.96B ¥2.40B ¥2.73B ¥0.00M
FCF Free Cash Flow
¥-37.90M ¥0.00M ¥97.69M ¥70.87M ¥200.89M ¥232.85M ¥294.12M ¥-429.52M ¥16.22M ¥63.90M ¥70.72M ¥371.82M ¥992.76M ¥1.00B ¥849.19M ¥1.69B ¥1.23B ¥1.86B ¥2.27B ¥2.58B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥0.20 ¥0.15 ¥0.42 ¥0.49 ¥0.61 ¥-0.90 ¥0.03 ¥0.13 ¥0.15 ¥0.78 ¥1.43 ¥1.36 ¥1.11 ¥2.22 ¥1.63 ¥2.47 ¥3.00 ¥3.42 ¥0.00